Measuring the burden of cystic fibrosis: A scoping review.

Autor: Cheema ZM; Department of Medicine, McMaster University, Hamilton, Canada; Cystic Fibrosis Canada, Toronto, Canada., Gomez LC; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada., Johnson N; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada., Laflamme OD; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada., Rabin HR; Department of Medicine, Cumming School of Medicine at the University of Calgary, Calgary, Canada., Steele K; Cystic Fibrosis Canada, Toronto, Canada., Wallenburg J; Cystic Fibrosis Canada, Toronto, Canada., Leong J; Department of Medicine, Cumming School of Medicine at the University of Calgary, Calgary, Canada., Cheng SY; Cystic Fibrosis Canada, Toronto, Canada., Quon BS; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada., Stephenson AL; Division of Respirology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada., Wranik WD; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada; Department of Public and International Affairs, Faculty of Management, Dalhousie University, Halifax, Canada., Sadatsafavi M; Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Stanojevic S; Department of Community Health, and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada. Electronic address: Sanja.Stanojevic@dal.ca.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Sep; Vol. 23 (5), pp. 823-830. Date of Electronic Publication: 2023 Dec 03.

Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Autor: Takhar P; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada., Geirnaert M; CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada., Gavura S; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada., Beca J; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON M5G 2L3, Canada., Mercer RE; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON M5G 2L3, Canada.; Evaluative Clinical Services, Sunnybrook Research Institute, Toronto, ON M4N 3M3, Canada., Denburg A; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada., Muñoz C; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON M5G 2L3, Canada., Tadrous M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.; Women's College Hospital, Toronto, ON M5S 1B2, Canada., Parmar A; Division of Medical Oncology & Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M3, Canada.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada., Dionne F; Prioritize Consulting Ltd., Vancouver, BC V6S 2B3, Canada., Boehm D; Saskatchewan Cancer Agency, Regina, SK S4W 0G3, Canada., Chambers C; Alberta Health Services, Calgary, AB T5J 3E4, Canada., Craig E; New Brunswick Cancer Network, Fredericton, NB E3B 5G8, Canada., Trudeau M; Division of Medical Oncology & Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M3, Canada., Cheung MC; Evaluative Clinical Services, Sunnybrook Research Institute, Toronto, ON M4N 3M3, Canada.; Division of Medical Oncology & Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M3, Canada.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada., Houlihan J; Nova Scotia Health, Halifax, NS B3S 0H6, Canada., McDonald V; Independent Patient Representative, Toronto, ON M6G 2V3, Canada., Pechlivanoglou P; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada., Taylor M; BC Cancer, Kelowna, BC V1Y 5L3, Canada., Wasylenko E; Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada.; John Dossetor Health Ethics Centre, University of Alberta, Edmonton, AB T6G 2R7, Canada., Wranik WD; Department of Public and International Affairs, Faculty of Management, Dalhousie University, Halifax, NS B3H 4R2, Canada.; Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada., Chan KKW; Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON M5G 2L3, Canada.; Evaluative Clinical Services, Sunnybrook Research Institute, Toronto, ON M4N 3M3, Canada.; Division of Medical Oncology & Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M3, Canada.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Apr 01; Vol. 31 (4), pp. 1876-1898. Date of Electronic Publication: 2024 Apr 01.

Study protocol for CELLAR (COVID-related Eating Limitations and Latent dietary effects in the Atlantic Region): population-based observational study to monitor dietary intakes and purchasing during COVID-19 in four Atlantic Canadian provinces.

Autor: Mah CL; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada Catherine.Mah@dal.ca.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Foster K; Department of Sociology and Social Anthropology, Dalhousie University, Halifax, Nova Scotia, Canada., Jago E; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Hajizadeh M; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Luongo G; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Taylor N; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Fuller D; School of Human Kinetics and Recreation, Memorial University, St John's, Newfoundland and Labrador, Canada., Yi Y; Department of Community Health and Humanities, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada., Esan OT; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Lukic R; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Clarke M; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada., Wranik WD; Faculty of Management, Dalhousie University, Halifax, Nova Scotia, Canada., Brimblecombe JK; Department of Nutrition, Dietetics and Food, Monash University, Melbourne, Victoria, Australia.; Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia., Peeters A; Institute for Health Transformation, Deakin University, Melbourne, Victoria, Australia.

Publikováno v: BMJ open [BMJ Open] 2022 Apr 27; Vol. 12 (4), pp. e061660. Date of Electronic Publication: 2022 Apr 27.

The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach.

Autor: Wranik WD; Faculty of Management, School of Public Administration, Dalhousie University, Halifax, Canada.; Faculty of Medicine, Department of Community Health and Epidemiology, Dalhousie University, Halifax, Canada.; Jean Monnet European Union Centre of Excellence, Dalhousie University, Halifax, Canada., Székely RR; Division of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Mayer S; Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria., Hiligsmann M; Faculty of Health Medicine and Life Sciences, School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands., Cheung KL; Health Behaviour Change Research Group, Department of Health Sciences, College of Health and Life Sciences, Brunel University London, London, UK.

Publikováno v: Journal of medical economics [J Med Econ] 2021 Jan-Dec; Vol. 24 (1), pp. 846-856.

Implications of interprofessional primary care team characteristics for health services and patient health outcomes: A systematic review with narrative synthesis.

Autor: Wranik WD; School of Public Administration, Faculty of Management, Dalhousie University, Canada; Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Canada. Electronic address: dwl@dal.ca., Price S; School of Nursing, Faculty of Health Professions, Dalhousie University, Canada., Haydt SM; School of Public Administration, Faculty of Management, Dalhousie University, Canada., Edwards J; Shared Health Manitoba, Canada., Hatfield K; School of Journalism and Communication, Carleton University, Canada., Weir J; Halifax Partnership, Dalhousie University, Canada., Doria N; Maritime SPOR Support Unit, Dalhousie University, Canada.

Publikováno v: Health policy (Amsterdam, Netherlands) [Health Policy] 2019 Jun; Vol. 123 (6), pp. 550-563. Date of Electronic Publication: 2019 Apr 01.